Robert Hofmeister
Vermogen: - $ op 31-07-2026
Vermogen: - $ op 31-07-2026
Robert Hofmeister currently works at Molkerei Hainichen Freiberg GmbH & Co. KG, as Co-Managing Director.
Dr. Hofmeister also formerly worked at Alaunos Therapeutics, Inc., as Independent Director from 2023 to 2025, EMD Serono Research & Development Institute, Inc., as Global Head-Translational Immunotherapy from 2012 to 2015, and TCR2 Therapeutics, Inc., as Senior Vice President-Research & Development.
Dr. Hofmeister received his doctorate degree from the University of Regensburg.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-04-2025 | 0 ( -.--% ) | - $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
Molkerei Hainichen Freiberg GmbH & Co. KG
Molkerei Hainichen Freiberg GmbH & Co. KG Food: Meat/Fish/DairyConsumer Non-Durables Manufactures dairy and cheese products | Algemeen Directeur | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Directeur/Bestuurslid | 15-04-2025 |
| TCR2 THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 01-03-2022 |
EMD Serono Research & Development Institute, Inc. | Corporate Officer/Principal | 01-01-2015 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
University of Regensburg
University of Regensburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono Research & Development Institute, Inc. | |
Molkerei Hainichen Freiberg GmbH & Co. KG
Molkerei Hainichen Freiberg GmbH & Co. KG Food: Meat/Fish/DairyConsumer Non-Durables Manufactures dairy and cheese products | Consumer Non-Durables |
TCR2 Therapeutics, Inc.
TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau